Vishal Kapoor - 16 Feb 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Role
Director
Signature
/s/ Jeet Mahal, as Attorney-in-Fact
Issuer symbol
JSPR
Transactions as of
16 Feb 2023
Net transactions value
$0
Form type
4
Filing time
17 Feb 2023, 07:30:07 UTC
Next filing
08 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JSPR Stock Option (right to buy) Award $0 +109,383 $0.000000 109,383 16 Feb 2023 Voting Common stock 109,383 $1.83 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/3rd of the shares subject to the option shall vest on February 16, 2024, and 1/3rd of the shares subject to the option shall vest on each anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.